However, there were no objective abscopal responses, the primary endpoint of the study, suggesting that blocking TGFβ with radiotherapy was not sufficient to elicit an anti-tumor immune response to control systemic tumor growth. This evidence concerns the gene TGFB1 and neoplasm.